Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fulminant myocarditis as a late sequela of DRESS: two cases.
Bourgeois GP, Cafardi JA, Groysman V, Pamboukian SV, Kirklin JK, Andea AA, Hughey LC. Bourgeois GP, et al. Among authors: groysman v. J Am Acad Dermatol. 2011 Oct;65(4):889-890. doi: 10.1016/j.jaad.2010.12.013. J Am Acad Dermatol. 2011. PMID: 21920256 Free PMC article. No abstract available.
A review of DRESS-associated myocarditis.
Bourgeois GP, Cafardi JA, Groysman V, Hughey LC. Bourgeois GP, et al. Among authors: groysman v. J Am Acad Dermatol. 2012 Jun;66(6):e229-36. doi: 10.1016/j.jaad.2010.11.057. Epub 2011 Jun 11. J Am Acad Dermatol. 2012. PMID: 21658796 Review.
Sirolimus-associated regression of benign lymphangioendothelioma.
Hunt KM, Herrmann JL, Andea AA, Groysman V, Beckum K. Hunt KM, et al. Among authors: groysman v. J Am Acad Dermatol. 2014 Nov;71(5):e221-2. doi: 10.1016/j.jaad.2014.07.054. Epub 2014 Oct 15. J Am Acad Dermatol. 2014. PMID: 25438003 Free article. No abstract available.
Systemic sarcoidosis with unique vulvar involvement.
Watkins S, Ismail A, McKay K, Beckum K, Groysman V. Watkins S, et al. Among authors: groysman v. JAMA Dermatol. 2014 Jun;150(6):666-7. doi: 10.1001/jamadermatol.2013.7204. JAMA Dermatol. 2014. PMID: 24599231 No abstract available.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. JAMA Dermatol. 2024 Nov 27. doi: 10.1001/jamadermatol.2024.4796. Online ahead of print. JAMA Dermatol. 2024. PMID: 39602139
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
Rosmarin D, Passeron T, Pandya AG, Grimes P, Harris JE, Desai SR, Lebwohl M, Ruer-Mulard M, Seneschal J, Wolkerstorfer A, Kornacki D, Sun K, Butler K, Ezzedine K; TRuE-V Study Group. Rosmarin D, et al. N Engl J Med. 2022 Oct 20;387(16):1445-1455. doi: 10.1056/NEJMoa2118828. N Engl J Med. 2022. PMID: 36260792